Synchrony Financial Logo

Synchrony Financial

SYF-PA

(2.2)
Stock Price

21,37 USD

2.15% ROA

16.5% ROE

6.56x PER

Market Cap.

15.505.235.880,00 USD

110.63% DER

2.56% Yield

15.39% NPM

Synchrony Financial Stock Analysis

Synchrony Financial Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Synchrony Financial Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (17.85%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (0.9x) suggests it's undervalued, making it an attractive opportunity for investors.

3 ROA

The stock's ROA (2.15%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

6 Dividend

The company has consistently provided dividends over the past three years, indicating a reliable source of income for investors.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (290), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

8 DER

The company has a high debt to equity ratio (111%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

9 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Synchrony Financial Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Synchrony Financial Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Synchrony Financial Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Synchrony Financial Revenue
Year Revenue Growth
2011 8.706.000.000
2012 10.048.000.000 13.36%
2013 11.071.000.000 9.24%
2014 9.230.000.000 -19.95%
2015 9.747.000.000 5.3%
2016 10.972.000.000 11.16%
2017 12.367.000.000 11.28%
2018 13.284.000.000 6.9%
2019 13.312.000.000 0.21%
2020 11.162.000.000 -19.26%
2021 10.192.000.000 -9.52%
2022 16.005.000.000 36.32%
2023 21.416.000.000 25.27%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Synchrony Financial Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Synchrony Financial General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 596.000.000
2012 620.000.000 3.87%
2013 698.000.000 11.17%
2014 866.000.000 19.4%
2015 1.042.000.000 16.89%
2016 1.207.000.000 13.67%
2017 1.314.000.000 8.14%
2018 1.427.000.000 7.92%
2019 1.455.000.000 1.92%
2020 1.380.000.000 -5.43%
2021 1.501.000.000 8.06%
2022 1.681.000.000 10.71%
2023 876.000.000 -91.89%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Synchrony Financial EBITDA
Year EBITDA Growth
2011 4.038.000.000
2012 4.204.000.000 3.95%
2013 3.988.000.000 -5.42%
2014 4.439.000.000 10.16%
2015 4.840.000.000 8.29%
2016 5.037.000.000 3.91%
2017 4.969.000.000 -1.37%
2018 5.816.000.000 14.56%
2019 5.254.000.000 -10.7%
2020 2.180.000.000 -141.01%
2021 5.893.000.000 63.01%
2022 5.860.000.000 -0.56%
2023 3.332.000.000 -75.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Synchrony Financial Gross Profit
Year Gross Profit Growth
2011 8.706.000.000
2012 10.048.000.000 13.36%
2013 11.071.000.000 9.24%
2014 9.230.000.000 -19.95%
2015 9.747.000.000 5.3%
2016 10.972.000.000 11.16%
2017 12.367.000.000 11.28%
2018 13.284.000.000 6.9%
2019 13.312.000.000 0.21%
2020 11.162.000.000 -19.26%
2021 10.192.000.000 -9.52%
2022 16.005.000.000 36.32%
2023 21.416.000.000 25.27%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Synchrony Financial Net Profit
Year Net Profit Growth
2011 1.890.000.000
2012 2.119.000.000 10.81%
2013 1.979.000.000 -7.07%
2014 2.109.000.000 6.16%
2015 2.214.000.000 4.74%
2016 2.251.000.000 1.64%
2017 1.935.000.000 -16.33%
2018 2.790.000.000 30.65%
2019 3.747.000.000 25.54%
2020 1.385.000.000 -170.54%
2021 4.221.000.000 67.19%
2022 3.016.000.000 -39.95%
2023 2.512.000.000 -20.06%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Synchrony Financial Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 2
2012 3 0%
2013 2 0%
2014 3 0%
2015 3 0%
2016 3 0%
2017 2 0%
2018 4 33.33%
2019 6 40%
2020 2 -150%
2021 7 71.43%
2022 6 -16.67%
2023 6 -20%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Synchrony Financial Free Cashflow
Year Free Cashflow Growth
2011 838.000.000
2012 5.637.000.000 85.13%
2013 -1.593.000.000 453.86%
2014 5.340.000.000 129.83%
2015 6.184.000.000 13.65%
2016 6.823.000.000 9.37%
2017 8.916.000.000 23.47%
2018 9.342.000.000 4.56%
2019 8.990.000.000 -3.92%
2020 7.487.000.000 -20.07%
2021 7.099.000.000 -5.47%
2022 6.694.000.000 -6.05%
2023 2.482.000.000 -169.7%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Synchrony Financial Operating Cashflow
Year Operating Cashflow Growth
2011 5.516.000.000
2012 5.637.000.000 2.15%
2013 5.679.000.000 0.74%
2014 5.340.000.000 -6.35%
2015 6.184.000.000 13.65%
2016 6.823.000.000 9.37%
2017 8.916.000.000 23.47%
2018 9.342.000.000 4.56%
2019 8.990.000.000 -3.92%
2020 7.487.000.000 -20.07%
2021 7.099.000.000 -5.47%
2022 6.694.000.000 -6.05%
2023 2.482.000.000 -169.7%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Synchrony Financial Capital Expenditure
Year Capital Expenditure Growth
2011 4.678.000.000
2012 0 0%
2013 7.272.000.000 100%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Synchrony Financial Equity
Year Equity Growth
2012 4.582.000.000
2013 5.960.000.000 23.12%
2014 10.478.000.000 43.12%
2015 12.604.000.000 16.87%
2016 14.196.000.000 11.21%
2017 14.234.000.000 0.27%
2018 14.678.000.000 3.02%
2019 15.088.000.000 2.72%
2020 12.701.000.000 -18.79%
2021 13.655.000.000 6.99%
2022 12.873.000.000 -6.07%
2023 13.767.000.000 6.49%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Synchrony Financial Assets
Year Assets Growth
2012 53.462.000.000
2013 59.085.000.000 9.52%
2014 75.707.000.000 21.96%
2015 84.135.000.000 10.02%
2016 90.207.000.000 6.73%
2017 95.808.000.000 5.85%
2018 106.792.000.000 10.29%
2019 104.826.000.000 -1.88%
2020 95.948.000.000 -9.25%
2021 95.748.000.000 -0.21%
2022 104.564.000.000 8.43%
2023 112.939.000.000 7.42%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Synchrony Financial Liabilities
Year Liabilities Growth
2012 48.880.000.000
2013 53.125.000.000 7.99%
2014 65.229.000.000 18.56%
2015 71.531.000.000 8.81%
2016 76.011.000.000 5.89%
2017 81.574.000.000 6.82%
2018 92.114.000.000 11.44%
2019 19.866.000.000 -363.68%
2020 15.775.000.000 -25.93%
2021 14.507.000.000 -8.74%
2022 91.691.000.000 84.18%
2023 15.231.000.000 -502%

Synchrony Financial Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
40.63
Net Income per Share
5.71
Price to Earning Ratio
6.56x
Price To Sales Ratio
0.92x
POCF Ratio
1.92
PFCF Ratio
1.91
Price to Book Ratio
1.13
EV to Sales
0.89
EV Over EBITDA
2.79
EV to Operating CashFlow
1.86
EV to FreeCashFlow
1.86
Earnings Yield
0.15
FreeCashFlow Yield
0.52
Market Cap
15,51 Bil.
Enterprise Value
15,09 Bil.
Graham Number
65.2
Graham NetNet
166.03

Income Statement Metrics

Net Income per Share
5.71
Income Quality
3.42
ROE
0.18
Return On Assets
0.02
Return On Capital Employed
0.04
Net Income per EBT
0.77
EBT Per Ebit
0.67
Ebit per Revenue
0.3
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.17
Gross Profit Margin
0.96
Operating Profit Margin
0.3
Pretax Profit Margin
0.2
Net Profit Margin
0.15

Dividends

Dividend Yield
0.03
Dividend Yield %
2.56
Payout Ratio
0.19
Dividend Per Share
0.96

Operating Metrics

Operating Cashflow per Share
19.53
Free CashFlow per Share
19.53
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.13
Return on Tangible Assets
0.02
Days Sales Outstanding
1894.05
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0.19
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
44,53
Book Value per Share
33,09
Tangible Book Value per Share
229.41
Shareholders Equity per Share
33.09
Interest Debt per Share
44.38
Debt to Equity
1.11
Debt to Assets
0.13
Net Debt to EBITDA
-0.08
Current Ratio
0
Tangible Asset Value
95,43 Bil.
Net Current Asset Value
88,11 Bil.
Invested Capital
1.11
Working Capital
103,34 Bil.
Intangibles to Total Assets
0.02
Average Receivables
86,35 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.98

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Synchrony Financial Dividends
Year Dividends Growth
2020 1
2021 1 0%
2022 1 0%
2023 1 0%

Synchrony Financial Profile

About Synchrony Financial

Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. In addition, it provides debt cancellation products to its credit card customers through online, mobile, and direct mail; healthcare payments and financing solutions under the CareCredit, Pets Best, and Walgreens brands; payments and financing solutions in the apparel, specialty retail, outdoor, music, and luxury industries; and point-of-sale consumer financing for audiology products and dental services. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. It serves digital, health and wellness, retail, home, auto, powersports, jewelry, pets, and other industries. Synchrony Financial was founded in 1932 and is headquartered in Stamford, Connecticut.

CEO
Mr. Brian D. Doubles
Employee
20.000
Address
777 Long Ridge Road
Stamford, 06902

Synchrony Financial Executives & BODs

Synchrony Financial Executives & BODs
# Name Age
1 Mr. Brian J. Wenzel Sr.
Executive Vice President & Chief Financial Officer
70
2 Ms. Kathryn Harmon Miller
Senior Vice President of Investor Relations
70
3 Mr. Alberto Casellas
Executive Vice President and Chief Executive Officer of Health & Wellness
70
4 Mr. Jonathan S. Mothner Esq.
Executive Vice President & Chief Risk and Legal Officer
70
5 Mr. Brian D. Doubles
President, Chief Executive Officer & Director
70
6 Mr. David P. Melito
Senior Vice President, Chief Accounting Officer & Controller
70
7 Ms. Carol D. Juel
Executive Vice President and Chief Technology & Operating Officer
70
8 Ms. Trish Mosconi
Executive Vice President, Chief Strategy Officer & Corporate Development Leader
70
9 Mr. DJ Casto
Executive Vice President & Chief Human Resources Officer
70
10 Mr. Bart Schaller
Executive Vice President & Chief Executive Officer of Digital
70

Synchrony Financial Competitors